WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 73.50
+0.40 (0.55%)
Oct 8, 2026, 11:16 AM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.34 billion as of October 8, 2026. It is the 25,160th most valuable company in the world and the 1,344th biggest in Taiwan. Its market cap has decreased by 4.55% in one year.
Market Cap
3.34B
Enterprise Value
4.12B
Revenue
1.21B
Global Rank
Country Rank
#1,344 Taiwan
PE Ratio
14.55
ChartMarket Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.34B, a decrease of -2.55%. That is a compound annual growth rate of -0.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 3.34B | 0.14% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.76B |
| Hi-Clearance | 5.68B |
| Apex Biotechnology | 3.05B |
| Bonraybio | 2.83B |
| Applied BioCode | 2.75B |
| A Plus Biotechnology | 2.51B |
| Wellell | 2.45B |
| Medimaging Integrated Solution | 2.25B |